| Development History | Licensed in from Korea Institute of Science and Technology on 13th of Nov 2017 |
|---|---|
| EcML | MPLA Manufacturing Technology in order to maximize the immune response by activating the immune system in the body |
| Alum has been widely used as an adjuvant | ![]() |
The manufacturing technology of TLR4 agonist (MPLA), with its superior efficacy is preferred |
| TLR4 agonist (Monophosphoryl Lipid A) |
| ¡æ it catalyzes TLR and activates T-cells, B-cells, etc. |
| TLR (Toll like receptor) |
| ¡æ Immune cells sense bacteria and viruses through a sensor called TLR on cell membranes. TLR protects our body from exotic pathogens by activating the immune system. |




